North Star Investment Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,415
| Closed | -$27K | – | 1106 |
|
|
2018
Q1 | $27K | Buy |
1,415
+29
| +2% | +$553 | ﹤0.01% | 679 |
|
|
2017
Q4 | $27K | Buy |
1,386
+30
| +2% | +$584 | ﹤0.01% | 665 |
|
|
2017
Q3 | $29K | Buy |
1,356
+26
| +2% | +$556 | ﹤0.01% | 647 |
|
|
2017
Q2 | $28K | Buy |
1,330
+25
| +2% | +$526 | ﹤0.01% | 640 |
|
|
2017
Q1 | $25K | Buy |
1,305
+24
| +2% | +$460 | ﹤0.01% | 642 |
|
|
2016
Q4 | $22K | Buy |
1,281
+30
| +2% | +$515 | ﹤0.01% | 625 |
|
|
2016
Q3 | $23K | Buy |
1,251
+51
| +4% | +$938 | ﹤0.01% | 518 |
|
|
2016
Q2 | $21K | Buy |
1,200
+22
| +2% | +$385 | ﹤0.01% | 528 |
|
|
2016
Q1 | $21K | Buy |
1,178
+64
| +6% | +$1.14K | ﹤0.01% | 501 |
|
|
2015
Q4 | $26K | Buy |
+1,114
| New | +$26K | 0.01% | 467 |
|
|
2014
Q3 | – | Sell |
-1,010
| Closed | -$21K | – | 652 |
|
|
2014
Q2 | $21K | Buy |
+1,010
| New | +$21K | ﹤0.01% | 482 |
|